je.st
news
Zacks Investment Research Upgrades Shire PLC (SHPG) to "Hold"
2016-01-04 23:29:59| Biotech - Topix.net
According to Zacks, "Shire's third-quarter results were impressive with the company beating on both top- and bottom-line estimates. It holds a strong position in the ADHD market driven by Vyvanse.
Tags: research
hold
investment
upgrades
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||